Eyes On News Snippets In Our View
We’ve got eyes on Pre-Earnings news snippets on HIV & RSV Vaccines, Diabetes & Obesity, and New Year M&A.
January 25, 2023
Eyes on Pharma
We’re keeping our Eyes on Pharma – tracking the latest happenings in Healthcare. Join us each week on the PharmaTell Blog as we highlight a few of the trending topics in PharmaTell Studio.
Eyes On Reviews & Previews for BioPharma & MedTech
Eyes On Reviews and Previews for 2022 & 2023
December 28, 2022
Catching Up on current events
Eyes On the latest happenings in BioPharma – Approvals, ReSubmissions, and Withdrawals
November 26, 2022
Watching the Hematology Space
Recently, we’ve had Eyes On the Hema space – trying to keep up with the latest data and approvals for Hemophilia, Sickle Cell, and Beta Thalassemia. The therapies from BioMarin, bluebird bio, and Vertex are set to change the way these diseases are managed and hopefully provided a much needed improvement for patients.
October 10, 2022
Updated Intel: US Infant Formula Shortage + Zantac Litigation
Eyes On the latest Intel on Zantac Litigation and the FDA investigation into the US Baby Formula Shortage
September 26, 2022
Novo Nordisk Acquires Forma Therapeutics
This week we had Eyes On the acquisition of Forma Therapeutics by Novo Nordisk – a typically reticent player in the M&A arena.
September 5, 2022